Australian Therapeutic Goods Administration Approves the First... - 13 August 2020 08:00

SHANGHAI and MELBOURNE, Australia, Aug. 13, 2020 /PRNewswire-AsiaNet/ -- Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company, announced today the authorization of the first-in-human trial of ATG-017 (ERASER trial) by the Australian Therapeutic Goods Administration (TGA)...

  PHC Holdings Corporation and Ascensia Diabetes Care Announce F... - 11 August 2020 07:42

TOKYO and BASEL, Switzerland, August 11, 2020 /PRNewswire-AsiaNet/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term, implantab...

  Global Fund Launches Search for Inspector General - 11 August 2020 00:52

GENEVA, Aug. 11, 2020, /PRNewswire-AsiaNet/-- The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched a search for its next Inspector General. A seven-member nomination committee will help the Board of the Global Fund select the next Inspector General. The Board welcomes all c...

  miR Scientific Announces Validation of its Urine Based, Non-In... - 10 August 2020 21:30

NEW YORK, Aug. 10, 2020 /PRNewswire-AsiaNet/-- -- Validated Data Reinforces Capability to Molecularly Detect and Characterize Prostate Cancer with Concurrent Sensitivity and Specificity of Over 91% -- Data Support Integration of Sentinel Prostate Test(TM) in Patient Care Settings and Decisi...

  First liquid biopsy to receive FDA Approval for comprehensive ... - 08 August 2020 12:43

SINGAPORE, Aug. 8, 2020 /PRNewswire-AsiaNet/-- The U.S. Food and Drug Administration (FDA) has approved Guardant Health's liquid biopsy, Guardant360(R) CDx, for tumor mutation profiling in patients across all solid cancers. Logo-https://photos.prnasia.com/prnh/20200530/2817723-1LOGO LOGO ...

  First hospitals in U.S. implant next-generation cardiac device... - 08 August 2020 08:08

AUSTIN, Texas, Aug. 8, 2020 /PRNewswire-AsiaNet/ -- -- Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Los Robles Health System perform near simultaneous implantation of WATCHMAN FLX(TM) Left Atrial Appendage Closure (LAAC) On Aug. 5, 2020, physicians at the Tex...

  Co-Diagnostics, Inc. Logix Smart(TM) COVID-19 Test Authorized ... - 07 August 2020 20:30

SALT LAKE CITY, Aug. 7, 2020 /PRNewswire-AsiaNet/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that Australia has been added to the list of countries that have authorized the Logix Sm...

  US FDA Grants Rare Pediatric Disease Designation (RPDD) to Pax... - 07 August 2020 11:04

SYDNEY, NSW, Aug. 7, 2020 /PRNewswire-AsiaNet/-- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Ka...

  Dietary cholesterol and phytosterols contribute directly to he... - 07 August 2020 03:55

REYKJAVIK, Iceland, August 6, 2020, /PRNewswire-AsiaNet/-- Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system, University of Iceland, the Cop...

  Tessa Therapeutics Announces Results from Two Independent Phas... - 06 August 2020 22:11

SINGAPORE, Aug. 6, 2020 /PRNewswire-AsiaNet/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced the publication of results in the Journal of Clinical Oncology(https://ascopubs.org/doi/abs/10.1200/JCO.20.01342?journa...